ACTS-GC
Regimen
- Experimental
- adjuvant S-1 for 1 year
- Control
- surgery only
Population
Japanese patients with stage II/III gastric cancer after curative D2 gastrectomy
Key finding
3y OS 80.1% vs 70.1% (HR for death 0.68, 95% CI 0.52-0.87, P=0.003); 5y OS 71.7% vs 61.1% in long-term f/u (HR 0.669)
Source: PMID 17978289
Timeline
Guideline citations
- CSCO GASTRIC 2025 (p.65)⚠️ OCR source